USDA approves new oral Bordetella vaccine for dogsFebruary 1, 2026The oral vaccine is reportedly the first USDA-licensed ½ mL oral Bordetella bronchiseptica vaccine for dogs and is designed to “reduce adverse reactions by removing unwanted protein and debris and to improve patient comfort.”
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.
USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an anti–IL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.